Clincosm LogoSign in Get a demo

Advanced Solid Tumors

Showing NaN - NaN of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Houston, San Antonio, Toronto (M4076)

Recruiting
  • Advanced Solid Tumors
  • Houston, Texas
  • +2 more
Jul 13, 2022

Advanced Solid Tumors Trial in Grand Rapids, Houston, San Antonio (CPI-1205, ipilimumab)

Completed
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +2 more
May 16, 2022

Advanced Solid Tumors, Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Cancer Trial in

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • Orange, California
  • +5 more
May 4, 2022

Advanced Solid Tumors, Lymphoma, Multiple Myeloma Trial in Nashville, Houston (AZD0466)

Terminated
  • Advanced Solid Tumors
  • +3 more
  • Nashville, Tennessee
  • +1 more
Apr 22, 2022

Advanced Solid Tumors Trial in United States (FF-10832 Gemcitabine Liposome Injection)

Recruiting
  • Advanced Solid Tumors
  • FF-10832 Gemcitabine Liposome Injection
  • Scottsdale, Arizona
  • +4 more
Apr 7, 2022

Advanced Solid Tumors Trial in Worldwide (MSC2490484A (M3814), Fractionated RT, Cisplatin)

Completed
  • Advanced Solid Tumors
  • MSC2490484A (M3814)
  • +2 more
  • Fresno, California
  • +25 more
Apr 6, 2022

Advanced Solid Tumors Trial in United States (KSQ-4279, KSQ-4279 will be combined in separate cohorts, including combination

Recruiting
  • Advanced Solid Tumors
  • KSQ-4279
  • KSQ-4279 will be combined in separate cohorts, including combination with an oral PARPi (poly adenosine diphosphate-ribose polymerase inhibitor)
  • Boston, Massachusetts
  • +4 more
Apr 5, 2022

Advanced Solid Tumors Trial in Houston, Salt Lake City, Charlottesville (TP-3654)

Completed
  • Advanced Solid Tumors
  • Houston, Texas
  • +2 more
Apr 4, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Advanced Solid Tumors Trial in Indianapolis, Houston, Salt Lake City (KBP-5209)

Completed
  • Advanced Solid Tumors
  • Indianapolis, Indiana
  • +2 more
Feb 17, 2022

Advanced Solid Tumors Trial in Worldwide (LAG525, PDR001)

Completed
Has Results
  • Advanced Solid Tumors
  • New York, New York
  • +23 more
Jan 17, 2022

Advanced Solid Tumors Trial in Worldwide (AMG 404)

Active, not recruiting
  • Advanced Solid Tumors
  • AMG 404
  • Santa Monica, California
  • +33 more
Feb 4, 2022

Advanced Solid Tumors Trial in Worldwide (ALKS 4230, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • ALKS 4230
  • Pembrolizumab
  • Los Angeles, California
  • +48 more
Feb 1, 2022

Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)

Completed
  • Breast Cancer
  • +3 more
  • FPA150
  • Pembrolizumab
  • Scottsdale, Arizona
  • +17 more
Jan 6, 2022

Advanced Solid Tumors Trial in Worldwide (SHR-A1811)

Recruiting
  • Advanced Solid Tumors
  • Bronx, New York
  • +33 more
Dec 22, 2021

Advanced Solid Tumors, Gastric Cancer, Transitional Cell Carcinoma of the Bladder Trial in Korea, Republic of, Taiwan, United

Completed
Has Results
  • Advanced Solid Tumors
  • +2 more
  • Duarte, California
  • +25 more
Dec 9, 2021

Advanced Solid Tumors Trial in Worldwide (lurbinectedin (PM01183))

Completed
Has Results
  • Advanced Solid Tumors
  • lurbinectedin (PM01183)
  • Santa Monica, California
  • +39 more
Oct 21, 2021

Advanced Solid Tumors, Triple Negative Breast Cancer Trial in Houston, Beijing (TT-00420)

Active, not recruiting
  • Advanced Solid Tumors
  • Triple Negative Breast Cancer
  • Houston, Texas
  • +1 more
Oct 25, 2021

Advanced Solid Tumors Trial in Houston (ION537)

Recruiting
  • Advanced Solid Tumors
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 13, 2021

Advanced Solid Tumors, NSCLC Trial in United States (Phase I: X-396 (ensartinib), Phase II: X-396 (ensartinib))

Completed
  • Advanced Solid Tumors
  • Non-small Cell Lung Cancer
  • Phase I: X-396 (ensartinib)
  • Phase II: X-396 (ensartinib)
  • Duarte, California
  • +13 more
Oct 4, 2021

Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®

Recruiting
  • Melanoma (Excluding Uveal Melanoma)
  • +15 more
  • XmAb®23104
  • Yervoy® (ipilimumab)
  • San Diego, California
  • +15 more
Sep 20, 2021

Advanced Solid Tumors, Metastatic Colon Cancer, Metastatic Breast Cancer Trial in United States (Fruquintinib (HMPL-013))

Recruiting
  • Advanced Solid Tumors
  • +6 more
  • Fruquintinib (HMPL-013)
  • Phoenix, Arizona
  • +8 more
Aug 30, 2021

Advanced Solid Tumors Trial in Worldwide (MEDI4736)

Completed
Has Results
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +78 more
Apr 20, 2021

Advanced Solid Tumors Trial in United States (Talazoparib)

Completed
Has Results
  • Advanced Solid Tumors
  • Alhambra, California
  • +10 more
Feb 5, 2021

Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,

Completed
Has Results
  • Advanced Solid Tumors
  • +8 more
  • Modified FOLFOX6
  • +3 more
  • Duarte, California
  • +11 more
Feb 3, 2021